1. Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma
   Xia Qin et al, 2020, Journal of Translational Medicine CrossRef
2. Genetic Alteration, Prognostic and Immunological Role of Acyl-CoA Synthetase Long-Chain Family Member 4 in a Pan-Cancer Analysis
   Yongsheng Yu et al, 2022, Frontiers in Genetics CrossRef
3. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy
   Rui Sha et al, 2021, eBioMedicine CrossRef
4. Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy
   Matteo Rossi Sebastiano et al, 2019, International Journal of Molecular Sciences CrossRef
5. Reprogramming of Fatty Acid Metabolism in Gynaecological Cancers: Is There a Role for Oestradiol?
   Azilleo Kristo Mozihim et al, 2022, Metabolites CrossRef
6. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism
   Kaiyue Ding et al, 2023, Chinese Medical Journal CrossRef
7. Quadruple negative breast cancer
   Meiling Huang et al, 2020, Breast Cancer CrossRef
8. Splice-site variant in ACSL5: a marker promoting opposing effect on cell viability and protein expression
   Iván Pérez-Núñez et al, 2019, European Journal of Human Genetics CrossRef
9. A novel peroxisome-related gene signature predicts clinical prognosis and is associated with immune microenvironment in low-grade glioma
   Dandan Gao et al, 2024, PeerJ CrossRef
10. The Profile of MicroRNA Expression and a Group of Genes in Breast Cancer: Relationship to Tumor Progression and Immunohistochemical Status
    E. A. Filippova et al, 2021, Russian Journal of Genetics CrossRef
11. A Novel Peroxisome-Related Gene Signature Predicts Breast Cancer Prognosis and Correlates with T Cell Suppression
    Yunxiang Wang et al, 2024, Breast Cancer: Targets and Therapy CrossRef
12. Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non‐small cell lung cancer
    Lara Paula Fernández et al, 2020, Molecular Oncology CrossRef
13. ACSL1 Inhibits ALV-J Replication by IFN-Ⅰ Signaling and PI3K/Akt Pathway
    Qihong Zhang et al, 2021, Frontiers in Immunology CrossRef
14. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer
    Ehsan Gharib et al, 2020, PLOS ONE CrossRef
15. Identification of Latent Oncogenes with a Network Embedding Method and Random Forest
    Ran Zhao et al, 2020, BioMed Research International CrossRef
16. Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus–Positive MCC Cell Lines
    Tatjana Sauerer et al, 2021, Frontiers in Microbiology CrossRef
17. TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
    Xueke Shi et al, 2022, Journal of Hematology & Oncology CrossRef
18. ACSL1-Mediated Fatty Acid β-Oxidation Enhances Metastasis and Proliferation in Endometrial Cancer
    Ying Zhou et al, 2024, Frontiers in Bioscience-Landmark CrossRef
19. Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer
    Xiang-hua Yu et al, 2019, Life Sciences CrossRef
20. Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
    Lara P. Fernández et al, 2020, Frontiers in Oncology CrossRef
21. Comprehensive Analysis of Prognostic Microenvironment-Related Genes in Invasive Breast Cancer
    Yingrong Shi et al, 2022, Frontiers in Oncology CrossRef
22. Fatty acid activation in carcinogenesis and cancer development: Essential roles of long‑chain acyl‑CoA synthetases (Review)
    Yue Tang et al, 2018, Oncology Letters CrossRef
23. ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
    Jun Hou et al, 2022, Frontiers in Pharmacology CrossRef
24. Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy
    Zeinab Ghasemishahrestani et al, 2021, Current Medicinal Chemistry CrossRef
25. ACSL family: The regulatory mechanisms and therapeutic implications in cancer
    Jing Quan et al, 2021, European Journal of Pharmacology CrossRef
26. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation
    Qingyu Zhang et al, 2021, Oncogene CrossRef
27. Metabolism and immunity in breast cancer
    Deyu Zhang et al, 2021, Frontiers of Medicine CrossRef
28. The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma
    Yang Yang et al, 2023, Diagnostic Pathology CrossRef
29. Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
    Yongfeng Lai et al, 2024, Cell Metabolism CrossRef
30. Metabolic Gene Signature for Predicting Breast Cancer Recurrence Using Transcriptome Analysis
    Juan Feng et al, 2021, Future Oncology CrossRef
31. Characteristics of long‐chain acyl‐CoA synthetases in metabolism and cancer
    Linlin Zhang et al, 2023, Clinical and Translational Discovery CrossRef
32. Acyl-CoA Synthetase Medium-Chain Family Member 5–Mediated Fatty Acid Metabolism Dysregulation Promotes the Progression of Hepatocellular Carcinoma
    Lei Yang et al, 2024, The American Journal of Pathology CrossRef
33. Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells
    Meng-Chi Yen et al, 2018, International Journal of Molecular Sciences CrossRef
34. Arachidonic acid metabolism in health and disease
    Yiran Zhang et al, 2023, MedComm CrossRef